Vitamin D: Beyond skeletal health, vitamin D modulates neuroinflammation and neurotransmitter synthesis.² ⁷ Deficiency has been associated with increased ADHD risk in observational data.² ⁸,² ⁹
While causality cannot be established, these findings indicate that nutritional vulnerabilities may contribute to both the pathogenesis and the expression of ADHD symptoms.³ ⁰
Do ADHD Medications Directly Cause Deficiencies?
Contrary to popular concern, most studies have not found strong evidence that psychostimulant medications themselves directly cause measurable nutrient deficiencies..³¹,³² Controlled trials examining serum micronutrient levels before and after methylphenidate therapy generally show no significant depletion of iron, zinc, or magnesium over six to twelve months.³³
What these medications do affect is appetite regulation. Through dopaminergic and noradrenergic stimulation of hypothalamic satiety centres, methylphenidate and amphetamine derivatives suppress hunger.³ ⁴ This often results in lower caloric intake, slower growth velocity, and mild weight loss, particularly in the first months of treatment.³ ⁵ Long-term data indicate partial catch-up growth as tolerance to appetite suppression develops.³ ⁶
The potential nutritional consequence lies not in direct metabolic interference but in reduced dietary intake— especially of protein- and mineral-rich foods that children naturally avoid when appetite wanes.³ ⁷ Thus, any observed deficiency may be an indirect medication effect rather than a pharmacological depletion per se.³ ⁸
Appetite, Growth, and Nutrient Intake
Growth monitoring is a key recommendation in all paediatric ADHD guidelines.³ ⁹ Studies such as
Al Eid et al.( 2024) confirm an initial reduction in weight and BMI during early methylphenidate therapy, often stabilising within twelve months. ⁴⁰ While this short-term effect rarely leads to clinically significant malnutrition, ongoing surveillance is prudent for children with restricted eating patterns or pre-existing nutritional compromise. ⁴ ¹
The quality of dietary intake is as important as quantity. A child who skips lunch under the influence of medication may compensate later with carbohydratedense snacks rather than balanced meals, inadvertently exacerbating micronutrient insufficiency. ⁴ ² Educating families about nutrient-dense options, timing of medication with meals, and integrating structured supplementation plans can mitigate these risks. ⁴ ³, ⁴⁴
The Gut – Brain Axis and Nutrient Absorption
A more nuanced mechanism linking ADHD medication to nutritional status involves the gut microbiota. Recent metagenomic studies have demonstrated that children with ADHD have distinct microbial profiles even before medication exposure. ⁴⁵-⁴⁷ Reduced diversity and lower abundance of beneficial taxa such as Bacteroides stercoris and Faecalibacterium prausnitzii are frequently reported. ⁴⁸
Psychostimulant use appears to further modulate this microbial environment. Boonchooduang et al.( 2025) found that methylphenidate treatment was associated with decreased short-chain fatty acid( SCFA) production— particularly acetate and propionate— key metabolites that maintain mucosal integrity and facilitate mineral absorption. ⁵ Similarly, Stiernborg et al.( 2023) observed lower microbial evenness in medicated children, with potential downstream effects on vitamin B₁₂ synthesis pathways. ⁶ These findings align with research demonstrating that altered SCFA production may impair mucosal health, nutrient absorption, and inflammatory regulation. ⁷, ⁸
Bone Mineral Density and Micronutrient Utilisation
A 2023 systematic review by Burns et al. in Bone raised concerns that long-term psychostimulant exposure may reduce bone mineral density( BMD) in children with ADHD. ⁹ Although confounding factors such as reduced appetite, lower weight, and physical inactivity complicate interpretation,¹ ⁰ this observation underscores the interconnectedness of nutrient status, endocrine regulation, and medication effects.¹¹
Reduced BMD could reflect subtle calcium – vitamin D – magnesium imbalances or changes in bone turnover linked to dopaminergic modulation.¹²- ¹ ⁴ While causality remains unproven, clinicians should consider periodic assessment of vitamin D and bone markers in children undergoing multiyear stimulant therapy.¹ ⁵
Integrating Neurobiology and Nutrient Metabolism
The dopaminergic hypothesis of ADHD provides an elegant bridge between neurotransmitter pharmacology and nutrient biochemistry.¹ ⁶ Dopamine synthesis requires adequate levels of iron( a cofactor for tyrosine hydroxylase),¹ ⁷ zinc( involved in dopamine transport and receptor modulation),¹ ⁸ and vitamin B₆( required for the decarboxylation of L-DOPA).¹ ⁹
AJNM | Summer 2025 | 199